We are live on ! Find out more
AC

Athos Capital Portfolio holdings

AUM $324M
1-Year Est. Return 16.62%
This Fund
S&P 500
This Quarter Est. Return
+11.09%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
AUM
$195M
AUM Growth
+$195M
Cap. Flow
+$131M
Cap. Flow %
67.32%
Top 10 Hldgs %
70.46%
Holding
83
New
17
Increased
5
Reduced
33
Closed
27
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSBPW
51
DELISTED
LakeShore Biopharma Warrants
LSBPW
$103K 0.05%
128,981
-21,018
-14% -$1.1K
BBAI.WS icon
52
BigBear.ai Holdings Warrant
BBAI.WS
$38.4M
$86K 0.04%
57,178
-9,487
-14% -$3.05K
SPWRW
53
SunPower Inc Warrants
SPWRW
$538K
$59K 0.03%
+28,420
New +$9.23K
PIIIW icon
54
P3 Health Partners Inc Warrant
PIIIW
$130K
$54K 0.03%
37,052
-6,282
-14% -$1.37K
JGGCR
55
DELISTED
Jaguar Global Growth Corporation I Right
JGGCR
$13K 0.01%
64,151
-10,849
-14% -$2.06K
KYCHR
56
DELISTED
Keyarch Acquisition Corporation Rights
KYCHR
$4K ﹤0.01%
35,395
-4,605
-12% -$591
BBIO icon
57
CALL
BridgeBio Pharma
BBIO
$15.7B
-100,000
Closed -$1.72K
COCHW icon
58
Envoy Medical Warrant
COCHW
$425K
-33,332
Closed -$342
GMED icon
59
Globus Medical
GMED
$10.7B
-59,200
Closed -$3.52K
MBLY icon
60
Mobileye
MBLY
$2B
-20,000
Closed -$768
PERF.WS
61
DELISTED
Perfect Corp Warrants
PERF.WS
-200,000
Closed -$966
RPD icon
62
Rapid7
RPD
$645M
-67,900
Closed -$3.08K
SIMO icon
63
CALL
Silicon Motion
SIMO
$8.6B
-150,000
Closed -$10.8K
GRND.WS
64
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
-454,651
Closed -$2.51K
VCXB.WS
65
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
-90,684
Closed -$950
KYCH
66
DELISTED
Keyarch Acquisition Corporation Ordinary Shares
KYCH
-40,000
Closed -$418
CHEA
67
DELISTED
Chenghe Acquisition Co. Class A Ordinary Share
CHEA
-250,000
Closed -$2.67K
JGGC
68
DELISTED
Jaguar Global Growth Corporation I Class A Ordinary Shares
JGGC
-75,000
Closed -$794
SYNH
69
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-39,600
Closed -$1.67K
ADERW
70
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
-124,999
Closed -$1.35K
CHEAW
71
DELISTED
Chenghe Acquisition Co. Warrant
CHEAW
-124,999
Closed -$1.34K
LATGW
72
DELISTED
LatAmGrowth SPAC Warrants
LATGW
-37,499
Closed -$400
FORG
73
DELISTED
ForgeRock, Inc.
FORG
-31,300
Closed -$643
ARNC
74
DELISTED
Arconic Corporation
ARNC
-31,600
Closed -$935
BSAQ.WS
75
DELISTED
Black Spade Acquisition Co Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BSAQ.WS
-193,999
Closed -$2.01K

Similar funds

Athos Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Athos Capital held 83 positions worth $195M, up 152,094% from $128K the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Athos Capital deployed $131M of net new capital in Q3 2023, opening 17 new positions and adding to 5 existing holdings. Its largest new stake was Chindata Group Holdings Limited American Depositary Shares: 7,376,705 shares worth $61.2M.

By sector, the portfolio is most concentrated in Communication Services at 31% of assets, followed by Healthcare and Technology.

On the sell side, the largest reduction was Cartesian Growth Corp II, an estimated $613K trimmed.

  • Athos Capital's largest Q3 2023 buy was Chindata Group Holdings Limited American Depositary Shares: 7,376,705 shares worth $61.2M.
  • Athos Capital added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2023, an estimated $7.53M increase.
  • Athos Capital's biggest Q3 2023 reduction was Cartesian Growth Corp II, cutting an estimated $613K.
  • Athos Capital fully exited Black Spade Acquisition Co in Q3 2023, selling an estimated $4.01K.
  • Athos Capital's ten largest holdings make up 70% of its $195M portfolio in Q3 2023.
  • Athos Capital opened 17 new positions and closed 27 in Q3 2023.
  • Athos Capital's portfolio value rose 152,094% quarter-over-quarter to $195M.

Based on Athos Capital's 13F filing for Q3 2023, filed 14 Nov 2023.